Jade Teakell, MD
@jmteakell.bsky.social
PhD/MD, Nephrologist, Associate Professor & Fellowship APD @UTKidney || #PeritonealDialysis #WomenInNephrology #NephJC #KidneyEmoji #NSMC #NephSky || she/her Pokémon GO! Trainer Code 071789189132
0/10 Hey NephJC faithful, we are shaking it up. Given the 📉 attendance at live chats we’re changing to a summary 🧵& ❓ to answer, at your convenience. Still tag us #NephJC to get the discussion going! PS If we hear enough comments, we might bring chats back!😉
The #ISNWCN has high trial impact clinical trials to celebrate latest and more successful results in our nephro world To celebrate the joy of getting together, and to #NephItForward, we officially opened up the #NephJC Editorial Internship application www.nephjc.com/news/nephjc-...
Announcing the NephJC Editorial Internship — NephJC
Are you a curious, motivated nephrology fellow or early‑career faculty member with a passion for science communication? NephJC is inviting a small group of talented individuals to join our Editorial I...
nephjc.com
1/10 Welcome to #TenPostNephJC Can we move beyond slowing CKD → to actually repairing the kidney? Last #NephJC we discussed Rilparencel, a renal autologous cell therapy (REACT) infusion and its effect on eGFR slope.
World Kidney Day is coming, and we’ll celebrate the field’s momentum. This #NephJCshort is a reminder that some practices should stay relics. Extreme dietary restriction feels archaic when modern therapies can hit same renal pathways without the ritualized deprivation www.nephjc.com/news/2026/2/...
Dialysis delay at what cost? Protein restriction as a distraction in the age of GDMT — NephJC
The NephJC shorts on cost-efficiency of low-protein diets and ketoanalogues as a distraction from CKD-relevant therapies in the 21st century… wait, only if the comparator wouldn’t be dialysis.
nephjc.com
#NephSky #MedSky 🩸Blood is thicker than water 🌊 Thankfully we thinned out the 2026 KDIGO Anemia Guidelines for you to peruse. Come discuss what's new. Tuesday 2/24/26 at 9pm EST on Bluesky! Summary by @jeyakumarmeyyappan.bsky.social www.nephjc.com/news/kdigo-anemia
2026 KDIGO Anemia Management Guidelines — NephJC
This week, we will discuss 2026 KDIGO anemia management in patients with kidney disease
nephjc.com
It's #NephMadness time!! 👉 ajkdblog.org/2026/03/01/w... #NephJC #NephForward @ajkd.bsky.social
Welcome to #NephMadness 2026
Our beautiful baby has grown into a moody, hormonal teen. That’s right, it’s year 14 of NephMadness! Whether this is your first time or you are a seasoned veteran, we have all the inf…
ajkdblog.org
Oh, the weather outside is frightful 🥶🥶 But #NephJC is so delightful, and since you've no place to go #NephSky... Come discuss POTCAST: potassium goals and cardiac arrhythmias 1/27/26 at 9pm EST on #Bluesky Summary by @shelliefravel.bsky.social @salinesolut.bsky.social www.nephjc.com/news/potcast
POTCAST- K+ Pop and Arrhythmia Drop — NephJC
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
nephjc.com
1/10 Last #NephJC we discussed Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN #TenPostNephJC Given the central role of complement dysregulation in C3 glomerulonephritis, we assessed whether complement-targeted therapies confer therapeutic benefit. www.nejm.org/doi/full/10....
☀️ SHINE GET! ☀️ @inkstar.bsky.social is here to kick off the first run of #AGDQ2026 with Super Mario Sunshine Any%! Join us for the first of many runs all week long over at gdq.gg/live AND youtube.com/c/gamesdonequick
OH MY GOD, IT'S THAT TIME #AGDQ2026 IS NOW LIVE!!! Catch us all week this week showcasing incredible speedruns in benefit of @preventcancer.org at both: gdq.gg/live AND! youtube.com/c/gamesdonequick (we're co-streaming!!)
Did we (meaning "you" of course, because you voted) get them right? Is there something missing or is the order wrong? #NephJC #TopTenStories2025 Come discuss with an international cadre of nephrologists & other interested parties on 1/6/26 at 9 pm EST on #Twitter
Implementing Patient #Navigation for #Children with Chronic Kidney Disease #CKD #VisualAbstract by Jade Teakell, MD https://www.kireports.org/article/S2468-0249(25)00719-3/fulltext
It's 2026!🎉 We will be counting down the Top Ten Nephrology Stories of 2025 on 1/6/26 at 9 pm EST. Join us on TWITTER (it will always be Twitter to us). Come on by #NephJC faithful for a lively discussion! You picked & we're count'em down. www.nephjc.com/news/2025/1/3/top-stories-in-nephrology-2025
Top Stories in Nephrology 2025 — NephJC
2025 was rich in successful stories. Here are the top 10 that impressed our audience.
nephjc.com
T0a Welcome to #NephJC! Our last of 2025 🎉🍾 Tonight’s central question: Should we stop routine 3x per week renal replacement therapy (RRT) in AKI-D (dialysis requiring AKI) and switch to indication-based RRT?
Gracias! @dramiliflores.bsky.social #NephSky LIBERATE-D: El Resumen Visual — #NephJC www.nephjc.com/news/2025/12/14/liberate-d-el-resumen-visual
LIBERATE-D: El Resumen Visual — NephJC
En pacientes con lesión renal aguda en diálisis, se evaluó si una estrategia más conservadora impacta en la recuperación renal. ¿Será que menos es más? Únete a la discusión del ensayo clínico LIBERATE...
nephjc.com
The LIBERATE-D VA by @sejalplakhani.bsky.social Should we break the pattern of thrice weekly dialysis in AKI-D? #NephJC #NephSky www.nephjc.com/news/liberateva
LIBERATE-D: The Visual Abstract — NephJC
In patients with dialysis-dependent acute kidney injury, a conservative dialysis strategy was evaluated in the LIBERATE-D trial. Could less be more? Join the discussion in #NephJC, but first, check ou...
nephjc.com
We are discussing LIBERATE-D this week on AKI www.nephjc.com/news/liberat... Summary by @msocomd.bsky.social and @sejalplakhani.bsky.social ! #NephJC
Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D — NephJC
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
nephjc.com
Join us for the last #NephJC of 2025, 12/16/25 at 9pm EST!🥳 How soon should we withhold dialysis in AKI? We're discussing the LIBERATE-D trial #NephSky This one might just change your mind 🧠🧠 Blog by @msocomd.bsky.social and @sejalplakhani.bsky.social www.nephjc.com/news/liberated-aki
Dialyze Less, Recover More? AKI’s Chance to Get LIBERATE-D — NephJC
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
nephjc.com
Appreciate this excellent work showing GLP-1 agonists reduce mortality in patients on dialysis and improve their chances of receiving a transplant. Hopefully, it will help me get them approved for my patients through the VA. #nephsky journals.lww.com/cjasn/pages/...
1/10 Welcome to #TenPostNephJC Last #NephJC we discussed the PISCES study 🐟 on the role of fish oil on cardiovascular events in hemodialysis patients. This study was presented at Kidney Week with simultaneous publication, and was as unexpected as a shark attack🦈.
Before you sit down for turkey, register your team name at HCWvsHunger.org & rally your troops because #HCWvsHunger 2025 starts tonight! Currently missing #BladesNBougies, #ComfortFood, #UrineItToWinIt, #EatOurWords, #KetaMeals, #DocsOfAllTrades #RxHunger, #CureRNHunger #NourishtoFlourish & more!
Healthcare Workers vs Hunger
Healthcare workers vs Hunger is an annual friendly competition between teams of healthcare workers to help relieve food insecurity.
hcwvshunger.org
Still full after yesterday's #Thanksgiving feast? Be grateful & share the love to fill bellies in need IT'S #HCWvsHunger TIME!!! hcwvshunger.org for the 🍎 details! 🤩Team #UrineItToWinIt will shine 🤩 @kidneyboy.bsky.social @nephroseeker.medsky.social @hswapnil.medsky.social @mcstarr1.bsky.social
Healthcare Workers vs Hunger
Healthcare workers vs Hunger is an annual friendly competition between teams of healthcare workers to help relieve food insecurity.
hcwvshunger.org
👇Here are the proposals for the #TopNephrology stories in 2025 🔥 Remember, you can only vote for your favorites if you have subscribed to #NephJC newsletter 📬 Soon we'll send you the voting link. Check your email. www.nephjc.com/news/2025/11...
Which were the Top Nephrology Stories of 2024? — NephJC
Time to vote for the Top Stories of 2025
nephjc.com
The lineup of the #TopNephrology stories is live www.nephjc.com/news/2025/11... If you want to vote, you need to be signed up for the #NephJC Newsletter here www.nephjc.com/newsletter ASAP
Which were the Top Nephrology Stories of 2024? — NephJC
Time to vote for the Top Stories of 2025
nephjc.com
1/10 Last #NephJC we discussed the ORIGIN 3 trial which investigated the use of Atacicept in IgAN #TenPostNephJC Read the article 👇 www.nejm.org/doi/10....
An announcement www.nephjc.com/news/2025/11... #NephJC @kidneyboy.bsky.social and moi hand over the @nephjc.bsky.social reigns to @nephroseeker.medsky.social & @brianrifkin.bsky.social
Taking the reigns — NephJC
In April 2014, Swapnil and I launched NephJC—and within weeks we were overwhelmed by the sheer work of running a twice-monthly, Twitter-based journal club. Fortunately, we also had a deep bench of fri...
nephjc.com
Every year, #NephJC celebrates successful, practice-changing trials. ✨ Which trials do you think are deserving for #TopNephrology 2025? #nephsky 👇👇 Here's a throwback for 2024 www.nephjc.com/news/2024/1/...
Top Stories in Nephrology 2024 — NephJC
Should we call 2024 the Renaissance of nephrology? It was probably the richest year in RCTs in the nephrology world, reflected in the higher number of Late-Breaking Clinical Trials sessions at every b...
nephjc.com
